The COVID-19 pandemic was caused by the recently emerged β-coronavirus SARS-CoV-2.
SARS-CoV-2 has had a catastrophic impact, resulting in nearly 7 million fatalities worldwide …

Background: This document updates previously published Clinical Practice Guidelines for
the management of patients with acute respiratory distress syndrome (ARDS), incorporating …

Millions of people worldwide have chronic kidney disease (CKD). Affected patients are at
high risk for cardiovascular (CV) disease for several reasons. Among various comorbidities …

Background Azvudine has clinical benefits and acceptable safety against COVID-19,
including in patients with comorbidities, but there is a lack of available data for its use in …

Purpose To explore the effect of azvudine as compared to paxlovid for oral treatment of
hospitalized patients with SARS-CoV-2 infection. Methods We analyzed data from a cohort …

Background Azvudine has been approved for the treatment of coronavirus disease 2019
(COVID-19) patients in China, and this meta-analysis aims to illustrate the safety of azvudine …

Understanding the dynamic changes in gene expression during Acute Respiratory Distress
Syndrome (ARDS) progression in post-acute infection patients is crucial for unraveling the …

Abstract Objectives The Australian National COVID-19 Clinical Evidence Taskforce has
been developing, maintaining, and disseminating living guidelines and decision support …

Background COVID-19 is continuing to ravage globally and has resulted in a huge health
and financial burden. Chinese proprietary medicines, such as Lianhua Qingwen (LHQW) …

Abstract Coronavirus disease 2019 (COVID-19) has been wreaking havoc for 3 years.
PANoptosis, a distinct and physiologically relevant inflammatory programmed cell death …